Susan is a solicitor with considerable experience in advising healthcare clients. This is what the Legal 500 said in its 2021 edition: ‘Susan Hunneyball, she has a mastery of both factual and legal issues. She has good client care skills and knows when to give robust advice. She is prepared to take a firm position when it is required, with the court, the opposition, or if necessary the client.’ ‘I worked with Susan Hunneyball for many years. She is one of very few lawyers in the country with extensive specialised knowledge of pharmacy law. She has a good – sympathetic – client manner which is particularly valuable for clients who, especially in fitness to practise cases or facing prosecution, are undergoing considerable stress. Her knowledge of NHS regulation in the primary care sector is detailed, and this is rare in a highly regulated area.’"...Encyclopedic knowledge of the healthcare sector. She combines a reassuring client presence with very good judgement as to what will work and what will not, and a willingness to get stuck in to try to solve the client’s problem.’In professional discipline matters Susan represents pharmacists in proceedings before the General Pharmaceutical Council, and advises on appeals from that body to the High Court. She also represents doctors in General Medical Council matters and advises dentists on issues arising from dental contracts. Susan has expertise in relation to appeals to the First Tier Tribunal. She is regularly instructed in applications for inclusion in the Pharmaceutical List and appeals to NHS Resolution, acting as solicitor advocate in the latter.Susan advises on legal issues for care homes; including CQC requirements and medicines management issues. She advises on inquests, public and administrative law (including judicial review) and acts for healthcare clients in relation to prosecutions, mainly high value fraud, brought by the CPS and other prosecuting agencies. In 2015 Susan was appointed to an MHRA advisory board (Advisory Board for the Registration of Homeopathic Products) and has since also been appointed to the MHRA Pharmacovigilance Expert Advisory Group and a further Expert Working Group.Susan is admitted to practise in England and Wales.